Max Rosett - Jan 31, 2024 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
EVP, OPERATIONS & INTERIM CFO
Signature
/s/ Sandra Stoneman, Attorney-in-Fact
Stock symbol
IMNM
Transactions as of
Jan 31, 2024
Transactions value $
$0
Form type
4
Date filed
1/31/2024, 08:53 PM
Previous filing
Oct 12, 2023
Next filing
May 17, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMNM Stock option (right to buy) Award $0 +175K $0.00 175K Jan 31, 2024 Common Stock 175K $16.57 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the options vest on January 31, 2025, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.